• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Narcolepsy

Narcolepsy - 25 Studies Found

COMPLETED : Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
: Narcolepsy With Cataplexy
: 2025-08-03
: Tablet
COMPLETED : A Study of TAK-861 in People With Narcolepsy Type 1
: Narcolepsy Type 1
: 2025-08-03
: Oral tablet.
COMPLETED : A Study of TAK-861 for the Treatment of Narcolepsy Type 1
: Narcolepsy Type 1
: 2025-08-03
: Oral tablet.
COMPLETED : Clarithromycin Mechanisms in Hypersomnia Syndromes
: Narcolepsy Without Cataplexy
: 2025-08-03
: Clarithromycin will be dosed as 500 mg twice daily, once upon awakening and once with lunch, for 14 days.
COMPLETED : Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
: Narcolepsy With Cataplexy
: 2025-08-03
: Tablet
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.